PARP-9通过IFIT-1上调CXCL10促进原发性干燥综合征单核细胞浸润
该研究基于30例原发性干燥综合征(pSS)患者及30例健康对照的外周血单个核细胞蛋白质组学,结合唇腺组织与NOD/LtJ小鼠实验,发现PARP-9在pSS中过表达并与CXCL10共定位,且随Chisholm评分升高而增加。机制上PARP-9通过STAT1磷酸化介导上调IFIT-1进而增加CXCL10表达,促进单核细胞浸润,提示PARP-9可能成为pSS新治疗靶点。
要点
- pSS患者唇腺中PARP-9与CXCL10过表达且共定位,PARP-9水平随Chisholm评分升高而增加。
- PARP-9通过STAT1磷酸化介导上调IFIT-1,进而增加B细胞CXCL10表达。
- NOD/LtJ小鼠中PARP-9与DTX3L存在于唾液腺浸润单核细胞,敲低PARP-9或DTX3L可观察效应。
核心结论
- PARP-9是原发性干燥综合征单核细胞浸润的调节因子,通过上调IFIT-1增加CXCL10表达,可能成为新的治疗靶点。
研究设计与样本
- 对30例原发性干燥综合征患者和30例健康对照的外周血单个核细胞进行蛋白质组学研究,筛选差异表达蛋白(P < 0.05;fold change >1.20)。
- 分离唇腺组织进行HE染色和免疫组化分析,磁珠分选纯化CD19+ B细胞进行免疫荧光、慢病毒-PARP-9转染和IFNα处理实验。
- 将PARP-9 siRNA和DTX3L siRNA递送至雌性NOD/LtJ小鼠以确定其效应。
主要发现
- PARP-9和CXCL10在原发性干燥综合征中过表达并共定位,唇腺PARP-9水平随Chisholm评分升高而增加。
- PARP-9和DTX3L存在于雌性NOD/LtJ小鼠模型唾液腺浸润单核细胞中。
- 差异表达蛋白的Ingenuity Pathway Analysis网络显示PARP-9、STAT1和IFIT-1参与IFN相关通路。
- PARP-9可上调B细胞中IFIT1和CXCL10的表达,且PARP-9和CXCL10可被IFNα诱导。
关键数值与推荐
- 蛋白质组学差异表达蛋白筛选标准:P < 0.05且fold change >1.20。
- 原发性干燥综合征患者样本量n = 30,健康对照n = 30。
临床怎么用
- PARP-9可能作为原发性干燥综合征单核细胞浸润及疾病进展的生物标志物或治疗靶点,但尚需临床验证。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mononuclear cell infiltration and type I interferon (IFN) system activation play an important role in primary Sjögren's syndrome (SS). We undertook this study to investigate the mechanism of poly(ADP-ribose) polymerase family member 9 (PARP-9) on mononuclear cell infiltration triggered by type I IFN. METHODS: A proteomic study was conducted in peripheral blood mononuclear cells from patients with primary SS (n = 30) and healthy controls (n = 30) to determine differentially expressed proteins (DEPs) (P < 0.05; fold change >1.20). Labial salivary glands (LSGs) were isolated for hematoxylin and eosin staining and immunohistochemical analysis. CD19+ B cells were purified by magnetic cell sorting for immunofluorescence staining, lentivirus-PARP-9 transfection, and IFNα treatment experiments. PARP-9 small interfering RNA (siRNA) and DTX3L siRNA were delivered into female NOD/LtJ female mice to determine their effect. RESULTS: The overexpression of PARP-9 and CXCL10 as well as their colocalization was confirmed in primary SS. PARP-9 levels in LSGs rose with increased Chisholm scores in patients with primary SS. PARP-9 and DTX3L were present in the infiltrating mononuclear cells from salivary glands in female NOD/LtJ mouse models. Additionally, Ingenuity Pathway Analysis networks of DEPs demonstrated that PARP-9, STAT1, and IFN-induced protein with tetratricopeptide repeats 1 (IFIT-1) participated in the IFN-related pathway. Furthermore, PARP-9 could up-regulate the expression of IFIT1 and CXCL10 in B cells. Moreover, PARP-9 and CXCL10 could be induced by IFNα in B cells. CONCLUSION: This study is the first to implicate PARP-9 as a regulator of infiltration of mononuclear cells in primary SS progression and to reveal that PARP-9 increases CXCL10 expression through up-regulating IFIT-1, which is mediated by the phosphorylation of STAT1. PARP-9 might therefore be a novel therapeutic target for primary SS.
引用
- Tian Q, Zhao H, Ling H, et al. Poly(ADP-Ribose) Polymerase Enhances Infiltration of Mononuclear Cells in Primary Sjögren's Syndrome Through Interferon-Induced Protein With Tetratricopeptide Repeats 1-Mediated Up-Regulation of CXCL10. Arthritis Rheumatol. 2020. PMID: 31876388. doi:10.1002/art.41195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。